MedTech Industry Dynamics
MedTech Industry Dynamics

InflammaSense has been selected as a performer on an ARPA-H CIRCLE program receiving up to $38 million, deploying its VITALx-patch wearable sensor to measure autonomic and inflammatory signatures in up to 200 critically ill patients across three clinical sites.

Okami Medical has received FDA expanded indication for its LOBO Vascular Occlusion System, extending its use into peripheral veins and broadening embolization options for patients with venous conditions such as pelvic venous disease and portal hypertension.

GE HealthCare has entered a definitive agreement to acquire SOFIE Biosciences, a U.S.-based PET radiopharmaceutical contract manufacturing organization, for $945 million in cash, establishing a “final mile” footprint for PET radiopharmaceutical supply and adding U.S. rights to the Phase III FAPI-74 radiotracer.

Archeon Medical has closed a $9 million (€7.5 million) Series A financing round to accelerate U.S. clinical validation and commercial scale-up of EOlife, a real-time ventilation feedback device designed to improve cardiac arrest resuscitation survival and neurological outcomes.
